Improved meal-related β-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year - Bo, A; Giovanni, P; James, E F; Anja, S (Diabetes Care, 2005)